MedPAC MedPAC Approves Part B Payment Recommendations Thomas Sullivan May 11, 2017 0 In early April, during the first session of the Medicare Payment Advisory Commission’s (MedPAC’s) public meeting, the Commission…
ACCME ABIM and ACCME Increase CME and QI Opportunities for Physicians Thomas Sullivan May 10, 2017 0 The American Board of Internal Medicine (ABIM) and the Accreditation Council for Continuing Medical Education (ACCME) have…
BioSimilar Biotechnology Investors Beware? Thomas Sullivan May 9, 2017 0 One thing the pharmaceutical stock industry has seen over many decades is price sensitivity to small statements and comments made…
Affordable Care Act The ACHA Passes the House Thomas Sullivan May 8, 2017 0 On Thursday, May 5, 2017, House Republicans finally got what they have been asking for, and campaigning on, for several years.…
Anti Kickback Novo Nordisk Settles Qui Tam Suit Thomas Sullivan May 5, 2017 0 Novo Nordisk is in the midst of settling a whistleblower lawsuit that alleges that the company ran a “white-coat marketing scheme”…
False Claims Act Genentech Beats FCA Suit, Thanks to Escobar Thomas Sullivan May 4, 2017 0 On Monday, May 1, 2017, the United States Court of Appeals for the Third Circuit stopped a False Claims Act suit that accused…
DOJ Mylan Settlement Classified as “Too Low” Thomas Sullivan May 3, 2017 0 Many of our readers may remember back in October 2016, when Mylan agreed to pay $465 million to settle claims related to the way…
Drug Prices New Analysis Shows Out-of-Pocket Spending Based on List Price Thomas Sullivan May 2, 2017 0 New analysis from Amundsen Consulting, a division of QuintilesIMS, shows that more than half of commercially insured patients’…
Drug Prices Drug Shortages, Pricing, and Regulatory Activity Thomas Sullivan May 1, 2017 0 In a paper titled Drug Shortages, Pricing, and Regulatory Activity, Christopher Stromberg of Bates White Economic Consulting…